Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2001
12/04/2001US6326181 Cell volume-regulated human kinase h-sgk
12/04/2001US6326179 Enzymatic immunoglobulin; for use as therapeutic and diagnostic tools in treatment of arthritis, viral disease and alzheimer's disease
12/04/2001US6326141 Detecting pancreatic defect; evaluate humans for preferential gene expression, compare to healty human, amplified expression from preferential gene indicates pancreatic defect
12/04/2001US6326079 Substrate with a photocatalytic coating
12/04/2001US6326034 From yeast or saltbush; regulate glucose and lipid metabolism, insulin; treatment of diabetes, cardiovascular diseases and hyperlipidemia; nontoxic
12/04/2001US6326033 Compositions comprising santalins, santarubins for artificially coloring the skin
12/04/2001US6326027 Solid, oral dosage form, comprising tramadol or its salt in matrix providing at least twelve hour effectiveness
12/04/2001US6326023 Synergistic anti-malarial formulation
12/04/2001US6326020 As a nerve blocking agent, sodium channel blocker in combination with vasoconstrictors, adrenergic drugs, vanilloids, amphi-philic, or lipophilic solvents, glucocorticoids; prolonged or modality selective
12/04/2001US6326017 Applying polymer matrix impregnated with treatment drug directly to artery or vein and covering with a barrier to restrict the release of drug to the surface of the artery or vein to produce localized effect
12/04/2001US6325991 Methods and compositions for treating periodontal disease with an inhibitor of secretory phospholipase A2
12/04/2001CA2229814C Peripherally active anti-hyperalgesic opiates
12/04/2001CA2217953C A pharmaceutical composition containing n-chlorophenylcarbamates and n-chlorophenylthiocarbamates for inhibiting the growth of viruses and cancers
12/04/2001CA2214386C Optically active thiazolidinone derivatives
12/04/2001CA2208836C Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine
12/04/2001CA2171882C Inhibitors of .beta.-amyloid protein production
12/04/2001CA2158173C Method of treating addictive behaviors
12/04/2001CA2139948C Targeting somatic gene therapy to joints
12/04/2001CA2110260C Pyridonecarboxylic acid derivatives
12/04/2001CA2098301C Certain aminomethyl phenylimidazole derivatives; a new class of dopamine receptor subtype specific ligands
12/04/2001CA2049873C Anticoagulant combination of laci and sulfated polysaccharides
12/04/2001CA2042327C Pyrrolo¬2,3-b|indole-ketones and analogs, a process for their preparation and their use as medicaments
12/04/2001CA2040982C N-(3-fluoro-2-phosphonylmethoxypropyl) derivatives of purine and pyrimidine heterocyclic bases, their preparation and use
12/04/2001CA2040914C Treatment of erectile dysfunction
12/04/2001CA2027635C Erythropoietin isoforms
12/04/2001CA2000553C Process for the preparation of 7-substituted-hept-6-enoic and -heptanoic acids and derivatives and intermediates thereof
12/04/2001CA1341324C Esterase enzymes used in the process for the preparation of 2-arylpropionic acids
12/02/2001CA2349388A1 A pharmaceutical composition for the treatment of obesity or to facilitate or promote weight loss
11/2001
11/30/2001CA2348847A1 New isoxazole-sulfonamide endothelin antagonists
11/29/2001WO2001090421A2 Method of detecting inflammatory lung disorders
11/29/2001WO2001090360A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
11/29/2001WO2001090347A1 Antiviral antisense therapy
11/29/2001WO2001090345A2 Methods and compositions for enhancing the delivery of a nucleic acid to a cell
11/29/2001WO2001090341A1 Antisense modulation of pten expression
11/29/2001WO2001090306A2 Compositions and methods for modulating tumor specific expression
11/29/2001WO2001090251A1 Antimicrobial composition
11/29/2001WO2001090189A2 G-protein coupled receptor org3.
11/29/2001WO2001090162A1 Crystal structure data of cystalysin and use thereof for the design and preparation of inhibitor molecules
11/29/2001WO2001090159A2 Compositions and methods for delivery of a molecule into a cell
11/29/2001WO2001090156A2 Card domain containing polypeptides, encoding nucleic acids, and methods of use
11/29/2001WO2001090152A2 Compositions and methods for the therapy and diagnosis of breast cancer
11/29/2001WO2001090137A2 NOVEL SOLID BODY FORMS OF MESOPROGESTIN 11β-[4E-(HYDROXYIMINOMETHYL)-PHENYL]-17α-METHOXYMETHYL-17β-METHOXY-ESTRA-4,9-DIEN-3-ONE
11/29/2001WO2001090136A2 Triterpenoid derivatives
11/29/2001WO2001090130A1 Process for the preparation of pharmaceutically acceptable salts of (ss-rs)-s-adenosyl-l-methionine
11/29/2001WO2001090129A2 Prophylactic and therapeutic treatment of infectious, autoimmune and allergic diseases with mono and disaccharide-base compounds
11/29/2001WO2001090121A2 Methods and compositions for treating hepatitis c virus
11/29/2001WO2001090111A1 New process for the preparation of vinyl-pyrrolidinone cephalosporine derivatives
11/29/2001WO2001090110A1 Macrolides
11/29/2001WO2001090109A1 Heteroaryldiazabicycloalkanes as nicotinic cholinergic receptor ligands
11/29/2001WO2001090108A1 3-phenyl-imidazo-pyrimidine derivatives as ligands for gaba receptors
11/29/2001WO2001090106A2 Tryasolyl tropane derivatives as ccr5 modulators
11/29/2001WO2001090104A2 -(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as modulators of protein kinases
11/29/2001WO2001090103A2 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as protein kinase modulators
11/29/2001WO2001090101A1 Arylmethylamine derivatives for use as tryptase inhibitors
11/29/2001WO2001090100A1 Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides
11/29/2001WO2001090099A1 Fatty acid synthase inhibitors
11/29/2001WO2001090096A2 Triterpenoid derivatives and their use as antiproliferative agents
11/29/2001WO2001090095A1 Thiadiazole compounds useful as inhibitors of cysteine activity dependent enzymes
11/29/2001WO2001090094A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
11/29/2001WO2001090093A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
11/29/2001WO2001090092A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
11/29/2001WO2001090091A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
11/29/2001WO2001090090A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
11/29/2001WO2001090086A1 A polymorph of 5-(4-aminosulfonyl-3-fluorophenyl)-4-cyclohexyl-2-methyloxazole
11/29/2001WO2001090084A1 Benzodiazepine derivatives as app modulators
11/29/2001WO2001090083A1 1,4-diazepan-2,5-dione derivatives and their use as nk-1 receptor antagonists
11/29/2001WO2001090082A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
11/29/2001WO2001090081A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
11/29/2001WO2001090078A1 Pyrazole derivatives and their use as gastrin and cholecystokin in receptor ligands
11/29/2001WO2001090076A1 Fluoroalkoxy-substituted benzamide dichloropyridinyl n-oxide pde4 inhibitor
11/29/2001WO2001090075A1 Compositions for controlling animal ectoparasites
11/29/2001WO2001090074A2 BENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a)
11/29/2001WO2001090070A2 Caspase inhibitors and uses thereof
11/29/2001WO2001090069A1 Novel calcium receptor active molecules and method for preparing same
11/29/2001WO2001090068A2 Mannich base prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use a modulators of protein kinases
11/29/2001WO2001090067A1 Tyrosine phosphatase inhibitors
11/29/2001WO2001090061A1 5,6-trans-2-alkylvitamin d derivatives
11/29/2001WO2001090060A1 Disulfide derivatives useful for treating allergic diseases
11/29/2001WO2001090059A1 Aniline disulfide derivatives for treating allergic diseases
11/29/2001WO2001090057A1 Sulfonamide derivatives
11/29/2001WO2001090056A1 Sulfonamide derivatives
11/29/2001WO2001090052A1 Cyclic amino acid derivatives useful as pharmaceutical agents
11/29/2001WO2001090051A1 Phenylglycine derivatives
11/29/2001WO2001090049A1 Novel amorphous form of sertraline hydrochloride
11/29/2001WO2001090047A1 Novel mmp-2/mmp-9 inhibitors
11/29/2001WO2001090046A1 Triterpenoid derivatives
11/29/2001WO2001090035A1 Novel antibiotic compounds
11/29/2001WO2001089616A1 Aerosol container for formulations of salmeterol xinafoate
11/29/2001WO2001089589A1 A novel treatment for cough
11/29/2001WO2001089582A1 Preventives and remedies for pulmonary hypertension
11/29/2001WO2001089577A2 Conjugates of aminodrugs comprising an oxime bond
11/29/2001WO2001089574A1 Solid dispersion system of pranlukast with improved dissolution, and the preparing method thereof
11/29/2001WO2001089571A2 Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives
11/29/2001WO2001089570A2 Combination of growth hormone secretagogues and antidepressants
11/29/2001WO2001089569A1 Combinations of enzyme inhibitor-containing preparations and the use thereof
11/29/2001WO2001089566A1 Gene detection assay for improving the likelihood of an effective response to an erbb antagonist cancer therapy
11/29/2001WO2001089554A2 Treatment of acute coronary syndrome with glp-1
11/29/2001WO2001089545A1 Antiviral methods and compositions
11/29/2001WO2001089543A2 Use of proanthocyanidins as an active ingredient of a stimulator and l-arginine or its salts as a source of nitric oxide to relieve symptoms of erectile dysfuntion
11/29/2001WO2001089542A2 Composition for improving the cell protection comprising a lipophilic antioxidant and a hydrophilic antioxidant
1 ... 5954 5955 5956 5957 5958 5959 5960 5961 5962 5963 5964 5965 5966 5967 5968 5969 5970 5971 5972 5973 5974 ... 7860